Q2QL74 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicbvpv7gc62clspvclw2nhe4p3ufh2qmihrwgzcy7gptudxb3dtyu/metadata.json
IPFS of structure file: 
bafybeiagwj4p6zh55q35yo6a3fydenccycaygm6bni7afwynzu3dy2o5d4/AF-Q2QL74-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xD0b526Adb417eAE2429fFA90bDB5772CD9896317
First NFT owner address (bech32): 
genesis16z6jdtd5zl4wys5ll2gtmdth9nvcjcchhr2qze
Current NFT ID #58969 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
58969
Accession (UniProt):
Q2QL74
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Didelphis virginiana

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2QL74 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2QL74|CFTR_DIDVI Cystic fibrosis transmembrane conductance regulator OS=Didelphis virginiana OX=9267 GN=CFTR PE=3 SV=1 MQRSPLEKANFLSKLFFSWTRPILRKGFRQRLELSDIYQIPLSNSADYLSENLEREWDRELASKKKPKLINALRRCFFWRFVFHGIILYLGEVTKAVQPLLLGRIIASYDPDNKVERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHMGMQMRIALFSLIYKKTLKLSSRVLDKISTGQLISLLSNNLNKFDEGLALAHFVWIVPLQVVLLMGLLWDLLQASAFCGLAFLIVLALFQAWLGQMMMKYRERRAGKINERLVITSEMIDNIQSVKAYCWEEAMEKMIENLRETELKLTRKTAYVRYFNSSAFFFSGFFVVFLAVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKEEYKTLEYNLTTTDVVMENITAFWDEGFGELFVKAKQNNSDVKMSNGDNGLFFSNFSLLGTPVLKNISFKIEKGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNTVLGEGGITLSGGQRARISLARAIYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILITSKMEHLKKADKILILHEGSCYFYGAFSELQNLRPDFSSKLMGYDSFDQFSAERRSSILTETLRRFSIEGDTAVSWNEGKKQSFKQTGDFGERRKNSILNPLNSIRKFSVVQKGQPQMNGIEENDDEPLERRLSLVPDSEQGEAILPRSNIINTGPTFQGRNRRQSVLNLMTRPSISQGQNMFKTGNAARKMSMAPQSKLSEIDIYSRRLSQDSGMDISDEINEEDLKEWFFDDVENIPAVTTWNTYLRYITIHKNLVFVLIWCLVIFLVEVAASLVGLWLLEDISFKDKTNGTNGANNTFPVIITDTSKYYLFYIYVGIADTFFALGIFRGLPLVHTLISVSKILHHKMLYSVLKAPMSTFNTLKPGGILNRFSKDIAILDDLLPLTIFDFIQLILIVVGALIVVSAIRPYIFLATVPVIIAFIMLRAYFLQTSQQLKQLESEARTPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTASWFLYLSTLRWFQMRIELVFVIFFIAVTFISILTTGDGEGRVGILLTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEEPLPAKPTKSLKKNQLSQVLIIENEHVNKENNWPSGGQMIVKDLTAKYTDGGNAVLENISFSISPGQRVGLLGRTGSGKSTLLAAFLRLLNTEGEMQIDGVSWDSIPLQKWRKAFGVIPQKVFIFSGTFRKNLDPYGQWSDHELWKVADEVGLKSVIEQFPGKLDFVLVDGGYVLSHGHKQLICLARSVLSKAKILLLDEPSAHLDPITYQIIRRVLKNAFANCTVILSEHRIEAMLECQRFLVIEDNKVRQYESIQKLVNEKSLYRQAISHSDRMKLFPHRNSSRHKSLAKITALKEETEEEVQETRL